These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2594551)

  • 21. Immunochemotherapy of advanced colorectal cancer with alpha-interferon and 5-fluorouracil. 1. Toxicological studies.
    De Vecchis L; Nunziata C; Ricci F; Cucchiara G; Picconi A; Bonmassar G; Lagomarsino Caprino M; Bonmassar E
    J Chemother; 1989 Apr; 1(2):128-35. PubMed ID: 2732781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure to increase 5-fluorouracil activity with interferon-alpha 2a in the treatment of advanced colorectal cancer.
    Martoni A; Bidin L; Zamagni C; Cricca A; Pannuti F
    Eur J Cancer; 1995; 31A(1):127. PubMed ID: 7695965
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working Party.
    van Herpen CM; Jansen RL; Kruit WH; Hoekman K; Groenewegen G; Osanto S; De Mulder PH
    Br J Cancer; 2000 Feb; 82(4):772-6. PubMed ID: 10732744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro data supporting interferon plus cytotoxic agent combinations.
    Von Hoff DD
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):58-61. PubMed ID: 1948130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetic aspects of the combination of interferon-alpha-2b and folic acid with fluorouracil].
    Czejka MJ; Jäger W; Schüller J; Fogl U; Schernthaner G
    Arzneimittelforschung; 1991 Aug; 41(8):860-3. PubMed ID: 1781811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exacerbation of multiple sclerosis after the administration of recombinant human interferon alfa.
    Larrey D; Marcellin P; Fréneaux E; Pessayre D; Benhamou JP
    JAMA; 1989 Apr; 261(14):2065. PubMed ID: 2494361
    [No Abstract]   [Full Text] [Related]  

  • 27. Cytokine-based biotherapy of gastrointestinal tumors.
    Buer J; Kirchner H; Schomburg A; Schüler A; Manns M; Lopez-Hänninen E; Duensing S; Poliwoda H; Atzpodien J
    Clin Investig; 1994 Jul; 72(7):526-34. PubMed ID: 7981582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune thrombocytopenia and interferon alfa.
    Kanfer EJ; McCarthy DM
    BMJ; 1988 Dec; 297(6663):1613. PubMed ID: 3147106
    [No Abstract]   [Full Text] [Related]  

  • 29. Interferon-alpha induces renal dysfunction and injury.
    Phillips TM
    Curr Opin Nephrol Hypertens; 1996 Jul; 5(4):380-3. PubMed ID: 8823539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Fluorouracil and levamisole in colorectal carcinoma.
    Grem JL
    Cancer Invest; 1990; 8(2):283-4. PubMed ID: 2400948
    [No Abstract]   [Full Text] [Related]  

  • 31. Induction of hyperthyroidism by interferon-alpha-2b.
    Schultz M; Müller R; von zur Mühlen A; Brabant G
    Lancet; 1989 Jun; 1(8652):1452. PubMed ID: 2567459
    [No Abstract]   [Full Text] [Related]  

  • 32. Alpha-interferon therapy and cutaneous vascular lesions.
    Dreno B; Huart A; Billaud E; Litoux P; Godefroy WY
    Ann Intern Med; 1989 Jul; 111(1):95-6. PubMed ID: 2786685
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of interferon-alpha-2b on the blood-plasma levels of intraarterial administered fluorouracil.
    Czejka MJ; Schuller J; Fogl U; Weiss C
    Pharmazie; 1991 Nov; 46(11):817-8. PubMed ID: 1811238
    [No Abstract]   [Full Text] [Related]  

  • 34. Human leukocyte alpha interferon-induced transient neurotoxicity in children.
    Katz JA; Mahoney DH; Steuber CP; Fernbach DJ
    Invest New Drugs; 1988 Jun; 6(2):115-20. PubMed ID: 3170131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The AXIS colorectal cancer trial: randomization of over 2000 patients. The AXIS Steering Group.
    Br J Surg; 1994 Nov; 81(11):1672. PubMed ID: 7827904
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical toxicities of the combination of 5-fluorouracil and recombinant interferon alfa-2a: an unusual toxicity profile.
    Wadler S; Lyver A; Wiernik PH
    Oncol Nurs Forum; 1989; 16(6 Suppl):12-5. PubMed ID: 2594551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical update on the role of fluorouracil and recombinant interferon alfa-2a in the treatment of colorectal carcinoma.
    Wadler S; Wiernik PH
    Semin Oncol; 1990 Feb; 17(1 Suppl 1):16-21; discussion 38-41. PubMed ID: 2405491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I trial of 5-fluorouracil and recombinant alpha 2a-interferon in patients with advanced colorectal carcinoma.
    Wadler S; Goldman M; Lyver A; Wiernik PH
    Cancer Res; 1990 Apr; 50(7):2056-9. PubMed ID: 2317795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluorouracil and recombinant interferon alfa-2a in advanced gastrointestinal neoplasms.
    Pazdur R
    Br J Haematol; 1991 Oct; 79 Suppl 1():56-9. PubMed ID: 1931711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-Fluorouracil and recombinant interferon alfa-2a: review of activity and toxicity in advanced colorectal carcinomas.
    Pazdur R; Jackson D; Shepherd B; Saddler D; Font L; McCardell M; Myers P; Schmidt S
    Oncol Nurs Forum; 1991; 18(1 Suppl):11-7. PubMed ID: 1997972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.